Seres Therapeutics CTO David Ege receives $5.3M in 2020

Seres Therapeutics reports 2020 executive compensation

By ExecPay News

Published: April 30, 2021

Seres Therapeutics reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, three executives at Seres Therapeutics received on average a compensation package of $3.3M, a 189% increase compared to previous year.
Average pay of disclosed executives at Seres Therapeutics
David S. Ege, Chief Technology Officer, received $5.3M in total. 97% of Ege's compensation, or $5.2M, was in option awards. Ege also received $65K in bonus, $77K in salary, as well as $785 in other compensation.
Eric Shaff, Chief Executive Officer, received a compensation package of $3.1M, which increased by 54% compared to previous year. 65% of the compensation package, or $2.1M, was in option awards.
Thomas DesRosier, Chief Legal Officer, earned $1.4M in 2020, a 47% increase compared to previous year.

Related executives

Eric Shaff

Seres Therapeutics

Chief Executive Officer

Thomas DesRosier

Seres Therapeutics

Chief Legal Officer

David Ege

Seres Therapeutics

Chief Technology Officer

You may also like

Source: SEC filing on April 30, 2021.